Searched for
NPPA NOTICE
Torrent Pharma gets demand notice of Rs 6.32 lakh from NPPATorrent Pharmaceuticals has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) amounting to Rs 6.32 lakh. T...- FOPE urges pause on NPPA notice, citing potential losses for pharma industryFOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...
- HC quashes NPPA demand notices to Bharat Serums, Bard for allegedly overcharging on drugs, medical devices"Accordingly, and for all the aforesaid reasons, the writ petitions shall stand allowed. The impugned orders dated July 5, 2018, and June 2...
- AstraZeneca Pharma India moves Delhi High Court against NPPA demand noticeThe notice of demand alleges that the company has overcharged about Rs 157.38 crore during the period from March 8, 2019 to January 31, 202...
- Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
- NPPA lens on five pharma companies for Hepatitis C drug overchargeNPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepa...
- NPPA to penalise companies offering freebies on stent salesInstances have come to the notice of NPPA that few companies dealing with coronary stents have come up with freebies by announcing schemes.
- Stents pricing: Govt asks hospitals to make prompt refundsThe National Pharmaceutical Pricing Authority (NPPA) said the matter would end there for such hospitals if there were no further complaints.
- NPPA sends show cause notices to hospitals over stent overpricing allegationsThese show cause notices have been sent after preliminary investigations into these allegations, the regulator disclosed on its official ac...
- Max Healthcare, Lilavati deny overcharging on stentsWe have not overcharged even a single patient for stent. We have complied fully and immediately with the NPPA order on stent pricing, a Max...
- NPPA seeks over Rs 1,000 crore from drug makers following SC winThe notice had then kicked off a controversy with the industry blaming the pricing watchdog of exceeding its brief.
- NPPA issues notices to drug companies over violations of DPCO 2013NPPA has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns thro...
- Notices issued to 263 pharma companies for overcharging in FY16The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliamen...
- NPPA to settle disputes with drug makers for over-charging medicinesCipla has been locked in battles with the NPPA in Allahabad, Bombay and Karnataka. In 2013, the SC transferred Cipla’s Bombay High Court pe...
- Delhi HC stays Rs 1.35 crore demand slapped on Novartis by NPPANovartis has challenged the 15% interest charged by NPPA on the overcharged amount saying it was contrary to the HC decision on another mat...
- NPPA demands Rs 130 cr from drug makers for overcharging: Srikant Kumar Jena"A number of drug companies have been found to be selling some of their medicines to the consumers at a price higher than the ceiling price...
- Demand notices of Rs 2,358 cr issued for drug overchargingPharma firms which have been issued notices are Cipla, Ranbaxy Laboratories & Dr Reddy's Laboratories as per NPPA's website.
- Cipla receives demand notices from NPPA for Rs 73 crThe company has received further demand notices from the government demanding an amount of Rs 47.70 crore in respect of the drug Salbutamol.
- Pharma cos may face penalties for overpricingDrugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face stat...
- NPPA may lose some autonomyDrug price regulator the National Pharmaceutical Pricing Authority (NPPA) may lose some of its autonomy soon.
Load More
